Skip to main content
SpringerLink
Log in

Current Controversies Concerning Sentinel Lymph Node Biopsy for Breast Cancer

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background and methods. The objectives of this article are to review existing controversies regarding sentinel lymph node (SLN) biopsy and to identify potential areas of consensus in order to eliminate routine axillary lymph node dissection (ALND).

Results. A combination of peritumoral injection with radioisotopes and subdermal or subareolar injection with blue dye may result in enhanced success rates of SLN identification. Preoperative lymphoscintigraphy is most useful for detecting an internal mammary SLN, but the practicability of internal mammary SLN biopsy is still in the investigative stage. Intraoperative diagnosis of SLN is useful because patients with SLN metastases may be treated immediately with ALND, but it is unreasonable to expect that either examination of frozen sections or imprint cytology will detect every metastatic disease. SLN micrometastases may be of prognostic importance and these can be identified with H&E staining on permanent sections of 200 µm intervals. While ALND is preferable for patients even with a small tumor (T1) and SLN micrometastases, radiation therapy is an acceptable alternative. SLN biopsy may be indicated for patients with DCIS detected as a palpable mass or those with large calcification areas in the breast. The accuracy of SLN biopsy after neoadjuvant chemotherapy is considered to be unproven.

Conclusion. Since SLN biopsy has been adopted by surgeons around the world, consistency of technique and case selection has attained great significance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Turner RR, Ollila DW, Krasne DL et al.: Histopathologic validation of the sentinel node hypothesis for breast carcinoma. Ann Surg 226: 271–278, 1997

    Google Scholar 

  2. Veronesi U, Paganelli G, Galimberti V et al.: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349: 1864–1867, 1997

    Google Scholar 

  3. Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify sentinel lymph nodes in breast cancer. Lancet 349: 1668–1669, 1997

    Google Scholar 

  4. Linehan DC, Hill AD, Akhurst T et al.: Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 6: 450–454, 1999

    Google Scholar 

  5. Roumen RMH, Valkenburg JGM, Gueskens LM: Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 23: 495–502, 1997

    Google Scholar 

  6. Klimberg VS, Rubio IT, Henry R et al.: Subareolar versus peritumoral injection for location of the sentinel lymph node. Am Surg 6: 860–865, 1999

    Google Scholar 

  7. Kern KA: Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 189: 539–545, 1999

    Google Scholar 

  8. Bauer TW, Spitz FR, Callans LS et al.: Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 9: 169–176, 2002

    Google Scholar 

  9. Roumen RMH, Gueskens LM, Valkenburg JGH: In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol 25: 347–351, 1999

    Google Scholar 

  10. Tanis PJ, Nieweg OE, Valdes Olmos RA et al.: Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 192: 390–409, 2001

    Google Scholar 

  11. McMasters K, Wong S, Martin R et al.: Dermal injection of radioactive colloid is superior to peritumoral injections for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233: 676–687, 2001

    Google Scholar 

  12. Kern KA: ‘Reply’ on lymphoscintigraphic anatomy of sentinel lymphatic channels. J Am Coll Surg 194: 846–848, 2002

    Google Scholar 

  13. Canavese G, Gipponi M, Catturich A et al.: Pattern of lymphatic drainage to the sentinel lymph node in breast cancer patients. J Surg Oncol 74: 69–74, 2000

    Google Scholar 

  14. Burak WE, Walker MJ, Yee LD et al.: Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 177: 445–449, 1999

    Google Scholar 

  15. McMasters KM, Wong SL, Tuttle TM et al.: Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 231: 724–731, 2000

    Google Scholar 

  16. Noguchi M, Tsugawa K, Miwa K et al.: Sentinel lymph node biopsy in breast cancer using blue dye with or without isotope localization. Breast Cancer 7: 287–296, 2000

    Google Scholar 

  17. Bass SS, Cox CE, Ku NN et al.: The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 189: 183–194, 1999

    Google Scholar 

  18. Benamor M, Nos C, Freneaux P et al.: Impact of internal mammary sentinel node imaging in breast cancer. Clin Nucl Med 28: 375–378, 2003

    Google Scholar 

  19. Uren RF, Howman-Giles RB, Thompson JF et al.: Mammary lymphoscintigraphy in breast cancer. J Nucl Med 36: 1775–1780, 1995

    Google Scholar 

  20. O’Hea BJ, Hill ADK, El-Shirbiny AM et al.: Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186: 423–427, 1998

  21. Krag D, Weaver D, Ashikaga T et al.: The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 339: 941–946, 1998

    Google Scholar 

  22. Veronesi U, Valagussa P: Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 47: 170–175, 1981

    Google Scholar 

  23. Veronesi U, Marubini E, Mariani L et al.: The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomized trial. Eur J Cancer 35: 1320–1325, 1999

    Google Scholar 

  24. Veronesi U, Cascinelli N, Greco M et al.: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202: 702–707, 1985

    Google Scholar 

  25. Noguchi M, Ohta N, Koyasaki N et al.: Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Cancer 68: 1918–1925, 1991

    Google Scholar 

  26. Goldhirsch A, Glick JH, Gelber RD et al.: Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 19: 3817–3327, 2001

    Google Scholar 

  27. Noguchi M, Tsugawa K, Miwa K: Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol 73: 75–80, 2000

    Google Scholar 

  28. Johnson N, Soot L, Nelson J et al.: Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg 179: 386–388, 2000

    Google Scholar 

  29. Van der Ent FWC, Kengen RAM, van der Pol HAG et al.: Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 234: 79–84, 2001

    Google Scholar 

  30. Freedman GM, Fowble BL, Nicolaou N et al.: Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 46: 805–814, 2000

    Google Scholar 

  31. Winchester DJ, Sener SF, Winchester DP et al.: Stentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients: efficacy of filtered technetium 99m sulfur colloid with overnight migration time. J Am Coll Surg 188: 597–603, 1999

    Google Scholar 

  32. Gulec SA, Moffat FL, Carroll RG et al.: Sentinel lymph node localization in early breast cancer. J Nucl Med 39: 1388–1393, 1998

    Google Scholar 

  33. Lucci Jr A, Kelemen PR, Miller III C, et al.: National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 192: 453–458, 2001

    Google Scholar 

  34. Veronesi U, Cascinelli N, Bufalino R et al.: Risk of internal mammary lymph-node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 198: 681–684, 1983

    Google Scholar 

  35. Noguchi M, Michigishi T, Nakajima K et al.: The diagnosis of internal mammary node metastases of breast cancer. Int Surg 78: 171–175, 1993

    Google Scholar 

  36. Galimberti V, Veronesi P, Arnone P et al.: Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol 9: 924–928, 2002

    Google Scholar 

  37. Noguchi M: Internal mammary sentinel node biopsy for breast cancer: is it practicable and relevant? (Review). Oncol Report 9: 461–468, 2002

    Google Scholar 

  38. Veronesi U, Paganelli G, Galimberti V et al.: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349: 1864–1867, 1997

    Google Scholar 

  39. Viale G, Bosari S, Mazzarol G et al.: Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85: 2433–2438, 1999

    Google Scholar 

  40. Rubio IT, Korourian S, Cowan C et al.: Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 5: 689–694, 1998

    Google Scholar 

  41. Schwartz GF, Giuliano AE, Veronesi U et al.: Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, 19-22 April 2002, Philadelphia, PA, USA. Breast J 8: 126–138, 2002

    Google Scholar 

  42. Motomura K, Inaji H, Komoike Y et al.: Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg 87: 597–601, 2000

    Google Scholar 

  43. Henry-Tillman RS, Korourian S, Rubio IT et al.: Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience. Ann Surg Oncol 9: 333–339, 2002

    Google Scholar 

  44. Lee A, Krishnamurthy S, Sahin A et al.: Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients. Cancer 96: 225–231, 2002

    Google Scholar 

  45. Llatjos M, Castella E, Fraile M et al.: Intraoperative assessment of sentinel lymph nodes in patients with breast carcinoma. Accuracy of rapid imprint cytology compared with definitive histologic workup. Cancer Cytopathol 96: 150–156, 2002

    Google Scholar 

  46. Dowlatshahi K, Fan M, Snider HC et al.: Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80: 1188–1197, 1997

    Google Scholar 

  47. Dowlatshahi K, Fan M, Bloom KJ, et al.: Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. A preliminary study. Cancer 86: 990–996, 1999

    Google Scholar 

  48. Tjan-Heijnen VCG, Bult P, de Widt-Levert LM et al.: Micrometastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 70: 81–88, 2001

    Google Scholar 

  49. Turner RR, Chu KU, Qi K et al.: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast cancer in a sentinel lymph node. Cancer 89: 574–581, 2000

    Google Scholar 

  50. Rosen PP, Lesse ML, Kinne DW et al.: Discontinuous or "skip’ metastasis in breast carcinoma: analysis of 1228 axillary dissections. Ann Surg 97: 276–283, 1983

    Google Scholar 

  51. Czerniecki BJ, Scheff AM, Callans LS et al.: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 85: 1098–1103, 1999

    Google Scholar 

  52. Chu KU, Turner RR, Hansen NM et al.: Do all patients with sentinel node metastases from breast carcinoma need complete axillary node dissection? Ann Surg 229: 536–541, 1999

    Google Scholar 

  53. Reynolds C, Mick R, Donohue JH et al.: Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17: 1720–1726, 1999

    Google Scholar 

  54. Viale G, Maiorano E, Mazzarol G et al.: Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92: 1378–1384, 2001

    Google Scholar 

  55. den Bakker MA, vanWeeszenberg A, de Kanter AY et al. Nonsentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol 55: 932–935, 2002

    Google Scholar 

  56. Hsueh EC, Turner RR, Glass EC et al.: Sentinel node biopsy in breast cancer. J Am Coll Surg 189: 207–212, 1999

    Google Scholar 

  57. Cody HS III.: Sentinel lymph node mapping in breast cancer. Breast Cancer 6: 13–22, 1999

    Google Scholar 

  58. Noguchi M.: Sentinel lymph node biopsy in breast cancer. Br J Surg 89: 21–34, 2002

    Google Scholar 

  59. Chung MA, DiPetrillo T, Hernandez S et al.: Treatment of the axilla by tangential breast radiotherapy in women with invasive breast cancer. Am J Surg 184: 401–402, 2002

    Google Scholar 

  60. Klauber-DeMore N, Tan LK, Liberman L et al.: Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 7: 636–642, 2000

    Google Scholar 

  61. Cox CE, Nguyen K, Gray RJ et al.: Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67: 513–519, 2001

    Google Scholar 

  62. Wasserberg N, Morgenstern S, Schachter J et al.: Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component. Arch Surg 137: 1249–1252, 2002

    Google Scholar 

  63. Intra M, Veronesi P, Mazzarol G et al.: Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138: 309–313, 2003

    Google Scholar 

  64. Pendas S, Dauway E, Giuliano R et al.: Sentinel node biopsy in DCIS patients. Ann Surg Oncol 7: 15–20, 2000

    Google Scholar 

  65. Lagios MD, Silverstein MJ: Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol 8: 275–277, 2001

    Google Scholar 

  66. Cox CE, Pendas S, Cox IM et al.: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227: 645–653, 1998

    Google Scholar 

  67. Breslin TM, Cohen L, Sahin A et al.: Sentinel node biopsy is accurate after neoadjuvant chemotherapy for beast cancer. J Clin Oncol 18: 3480–3486, 2000

    Google Scholar 

  68. Nason KS, Anderson BO, Byrd DR et al.: Increased false negative sentinel lymph node biopsy rates after preoperative chemotherapy for invasive breast cancer. Cancer 89: 2187–2194, 2000

    Google Scholar 

  69. Haid A, Tausch C, Lang A et al.: Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 92: 1080–1084, 2001

    Google Scholar 

  70. Piato JRM, Brros ACSD, Pincerato KM et al.: Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. EJSO 29: 118–120, 2002

    Google Scholar 

  71. Mamounas E, Brown A, Smith R et al.: Sentinel node biopsy (SNB) following neoadjuvant chemotherapy in breast cancer (BC): results from NSABP B-27. Society of Surgical Oncology 54th Annual Cancer Symposium, March 2001.

  72. Cohen LF, Breslin TM, Kuerer HM et al.: Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Pathol 24: 1266–1272, 2000

    Google Scholar 

  73. Anderson BO, Jewell K, Eary JF et al.: Neoadjuvant chemotherapy contraindicates sentinel node mapping in breast cancer. Proc ASCO 18: 71a, 1999

    Google Scholar 

  74. Julian TB, Patel N, Dusi D et al.: Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 182: 407–410, 2001

    Google Scholar 

  75. Hunt KK, Ross MI: Lymphatic mapping for breast cancer: surgical advance in evolution. Oncology 12: 1297–1298, 1998

    Google Scholar 

  76. Noguchi M: Is it necessary to perform prospective randomized studies before sentinel node biopsy can replace routine axillary dissection? Breast Cancer 10: 179–187, 2003

    Google Scholar 

  77. McNeil C: Four large studies aim to resolve sentinel node debate. J Natl Cancer Inst 90: 729, 1998

    Google Scholar 

  78. Noguchi M: Is it necessary to perform prospective randomized studies before sentinel node biopsy can replace routine axillary dissection? Breast Cancer 10: 179–187, 2003

    Google Scholar 

  79. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A et al.: Followup of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 77: 165–170, 2001

    Google Scholar 

  80. Roumen RMH, Kuijt GP, Liem IH et al.: Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 88: 1639–1643, 2001

    Google Scholar 

  81. Giuliano AE, Haigh PI, Brennan MB et al.: Prospective observational study of sentinel lymphadenectomy without Sentinel lymph node biopsy for breast cancer 271 further axillary dissection in patients with sentinel nodenegative breast cancer. J Clin Oncol 18: 2553–2559, 2000

    Google Scholar 

  82. Noguchi M: Sentinel lymph node biopsy in breast cancer: an overview of the Japanese experience. Breast Cancer 8: 184–194, 2001

    Google Scholar 

  83. Reitsamer R, Peintinger F, Prokop E et al.: Sentinel lymph node biopsy alone without axillary lymph node dissection-follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 29: 211–223, 2003

    Google Scholar 

  84. Tafra L, Lannin DR, Swanson MS et al.: Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233: 51–59, 2001

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Center, Kanazawa University Hospital, Kanazawa University, Takara-machi, Kanazawa, Japan

    Masakuni Noguchi

Authors
  1. Masakuni Noguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Noguchi, M. Current Controversies Concerning Sentinel Lymph Node Biopsy for Breast Cancer. Breast Cancer Res Treat 84, 261–271 (2004). https://doi.org/10.1023/B:BREA.0000019952.55284.f2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BREA.0000019952.55284.f2

Search

Navigation